Allergic rhinitis. Allergic rhinitis due to pollen
Conditions
Interventions
Intervention 1: Intervention group: Sublingual immunotherapy with drops manufactured by Wolwopharm in China with doses up to maintenance levels two drops of 1000 micrograms sublingual and for 6 months
Treatment - Drugs
Intervention group: Sublingual immunotherapy with drops manufactured by Wolwopharm in China with doses up to maintenance levels two drops of 1000 micrograms sublingual and for 6 months
Sponsors
Kashan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
12 Years to No maximum
Inclusion criteria
Inclusion criteria: Having Allergic Rhinitis Age over 12 years
Exclusion criteria
Exclusion criteria: Any Respiratory and non-respiratory inflammation such as infection; Recent Massive Surgery; Severe Pulmonary or Renal Disease; Alcohol Abuse; Sever Addiction; Uncontrolled Diabetes; Cancer; Autoimmune diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Interleukin 25. Timepoint: First and 24 weeks after intervention. Method of measurement: ELISA.;Interleukin 33. Timepoint: First and 24 weeks after intervention. Method of measurement: ELISA. | — |
Secondary
| Measure | Time frame |
|---|---|
| Disease severity. Timepoint: At the beginning of the study and 24 weeks after the intervention. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHassan Nikoueinejad
Bagheiat-allah University of Medical Sciences
Outcome results
None listed